top of page

We invest in
founder-led
science-led
biotechnology companies
with non-incremental strategies
for improving human health.

ContactForm

KF VENTURES

FEATURED INVESTMENTS

Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.

Acquired by Roche, Oct 2023

Onc.AI is a digital health company on a mission to radically improve oncology decision making.

Tegmine combines mass spectrometry, machine learning, and biology to develop highly selective antibody drug targets for oncology.

DotLab is a women’s healthcare technology company developing a circulating micro RNA blood test to diagnose active endometriosis.

Waypoint uses spatial biology and pooled screening to develop optimized cell therapies.

Stealth co.

Mol Dyn meets LLMs.

GET IN TOUCH:

Tel: ‪(415) 340-0839‬

San Francisco, CA 94110

© 2022-5 KF Ventures, LLC

CONTACT US:

Thanks for submitting!

bottom of page